TPMT mRNA Expression: A Novel Prognostic Biomarker for Patients with Colon Cancer by Bioinformatics Analysis

TPMT mRNA Expression: A Novel Prognostic Biomarker for Patients with Colon Cancer by Bioinformatics Analysis

Wei Jia, Yi-Fu He, Xiao-Jun Qian, Jian Chen Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People’s Republic of ChinaCorrespondence: Jian ChenDepartment of Medical Onc...

Full description

Bibliographic Details
Main Authors:	Jia W, He YF, Qian XJ, Chen J
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-01-01
Series:	International Journal of General Medicine
Subjects:	colon cancer tpmt prognosis bioinformatics
Online Access:	https://www.dovepress.com/tpmt-mrna-expression-a-novel-prognostic-biomarker-for-patients-with-co-peer-reviewed-fulltext-article-IJGM

Similar Items

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency
by: Debbie S. Deben, et al.
Published: (2023-10-01)

The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn’s Disease
by: Ha C, et al.
Published: (2020-11-01)

Thiopurine Drugs in the Treatment of Ulcerative Colitis: Identification of a Novel Deleterious Mutation in TPMT
by: Pierre-Olivier Harmand, et al.
Published: (2020-10-01)

Preemptive <i>TPMT</i> Genotyping and Adherence to Genotype-Based Therapeutic Recommendations Reduces the Healthcare Cost in Patients Receiving Azathioprine or 6-Mercaptopurine for Autoimmune Diseases
by: Sarahí Valdez-Acosta, et al.
Published: (2023-07-01)

TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned
by: Liuh Ling Goh, et al.
Published: (2022-09-01)

Bioinformatics Analysis of Prognostic miRNA Signature and Potential Critical Genes in Colon Cancer
by: Weigang Chen, et al.
Published: (2020-06-01)

Case Report: Multifocal EBV-Associated Diffuse Large B-Cell Lymphoma in a Patient With 6-MP Associated Lymphopenia With TPMT Deficiency
by: Lara Müller-Scholden, et al.
Published: (2022-05-01)

ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
by: Borhan Moradveisi, et al.
Published: (2019-08-01)

Individualized therapy: Role of thiopurine S-methyltransferase protein and genetic variants
by: Pavlović Sonja, et al.
Published: (2010-01-01)

NUDT15 and TPMT polymorphisms in three distinct native populations of the Brazilian Amazon
by: Jamila Alessandra Perini, et al.
Published: (2024-02-01)

Imputation of TPMT defective alleles for the identification of patients with high-risk phenotypes
by: Berta eAlmoguera, et al.
Published: (2014-05-01)

DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease
by: Davide Selvestrel, et al.
Published: (2023-01-01)

Association between the <i>TPMT*3C</i> (rs1142345) Polymorphism and the Risk of Death in the Treatment of Acute Lymphoblastic Leukemia in Children from the Brazilian Amazon Region
by: Darlen Cardoso de Carvalho, et al.
Published: (2020-09-01)

<i>TPMT*3C</i> as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia
by: Thawinee Jantararoungtong, et al.
Published: (2021-08-01)

Thiopurine S-Methyltransferase Polymorphisms Predict Hepatotoxicity in Azathioprine-Treated Patients with Autoimmune Diseases
by: Heh-Shiang Sheu, et al.
Published: (2022-08-01)

Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT
by: Yoomi Park, et al.
Published: (2020-07-01)

Population-Specific Distribution of TPMT Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine
by: Gallardo-Cóndor J, et al.
Published: (2023-11-01)

Long Noncoding RNA SNHG7 Is a Diagnostic and Prognostic Marker for Colon Adenocarcinoma
by: Chengwei Jiang, et al.
Published: (2022-06-01)

Bioinformatics analysis of the clinicopathological and prognostic significance of BAG3 mRNA in gynecological cancers
by: Zi-mo Wang, et al.
Published: (2023-12-01)

The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers
by: Cong-yu Zhang, et al.
Published: (2023-12-01)

Identification of hub genes and outcome in colon cancer based on bioinformatics analysis
by: Yang W, et al.
Published: (2018-12-01)

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis
by: Hua-chuan Zheng, et al.
Published: (2022-10-01)

Bioinformatic analysis of the clinicopathological and prognostic significance of oocyte-arresting BTG4 mRNA expression in gynecological cancers
by: Hua-chuan Zheng, et al.
Published: (2023-12-01)

Development and verification of a prognostic model for colon cancer on pyroptosis-related genes
by: Zizhen Wu, et al.
Published: (2022-09-01)

Variants in TPMT, ITPA, ABCC4 and ABCB1 genes as predictors of 6-mercaptopurine induced toxicity in children with acute lymphoblastic leukemia
by: Milošević Goran, et al.
Published: (2018-01-01)

Identification of a five‐mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor
by: Xiao‐Dan Lin, et al.
Published: (2020-01-01)

Expression, Function and Bioinformatic Analysis of Nicotinamide Phosphoribosyl Transferase in Colon Cancer
by: TANG Jun, et al.
Published: (2018-12-01)

A bioinformatics analysis of the clinicopathological and prognostic significance of FAM64A mRNA expression in gynecological cancers
by: Hua-Chuan Zheng, et al.
Published: (2023-12-01)

EPOR mRNA level: A valuable prognostic indicator for patients with ER+ breast cancer
by: Jing Pan, et al.
Published: (2018-01-01)

Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer
by: Yunze Liu, et al.
Published: (2022-05-01)

Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer
by: Ning Kang, et al.
Published: (2022-04-01)

FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
by: Deng Yifan, et al.
Published: (2023-12-01)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
by: Zhang Q, et al.
Published: (2021-03-01)

Aberrant methylation and microRNA-target regulation are associated with downregulated NEURL1B: a diagnostic and prognostic target in colon cancer
by: Jiaxin Liu, et al.
Published: (2020-07-01)

The E2F family as potential biomarkers and therapeutic targets in colon cancer
by: Haibo Yao, et al.
Published: (2020-02-01)

Polymorphisms of the <i>TPMT</i>, <i>NUDT15</i> genes and 6-mercaptopurine toxicity profile in adult patients with Ph-negative acute lymphoblastic leukemia/lymphomas on the ALL-2016 protocol
by: E. S. Kotova, et al.
Published: (2022-07-01)

Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma
by: Guoliang Cui, et al.
Published: (2022-09-01)

TCHH as a Novel Prognostic Biomarker for Patients with Gastric Cancer by Bioinformatics Analysis
by: Yu F, et al.
Published: (2024-02-01)

The clinicopathological significances and related signal pathways of BTG3 mRNA expression in cancers: A bioinformatics analysis
by: Hua-Chuan Zheng, et al.
Published: (2022-09-01)

Identification of novel prognostic circRNA biomarkers in circRNA-miRNA-mRNA regulatory network in gastric cancer and immune infiltration analysis
by: Jianing Yan, et al.
Published: (2023-06-01)